Medicalsystem Biotechnology Co., Ltd (SHE:300439)
China · Delayed Price · Currency is CNY 10.25
+0.10 (0.99%)
Feb 4, 2026, 3:04 PM CST
SHE:300439 Revenue
Medicalsystem Biotechnology had revenue of 399.45M CNY in the quarter ending September 30, 2025, a decrease of -12.71%. This brings the company's revenue in the last twelve months to 1.47B, down -19.24% year-over-year. In the year 2024, Medicalsystem Biotechnology had annual revenue of 1.74B, down -7.61%.
Revenue (ttm)
1.47B
Revenue Growth
-19.24%
P/S Ratio
2.65
Revenue / Employee
699.33K
Employees
2,104
Market Cap
3.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.74B | -143.44M | -7.61% |
| Dec 31, 2023 | 1.89B | -603.22M | -24.23% |
| Jan 1, 2023 | 2.49B | 237.55M | 10.55% |
| Dec 31, 2021 | 2.25B | -50.50M | -2.19% |
| Dec 31, 2020 | 2.30B | -831.42M | -26.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Maccura Biotechnology Co.Ltd | 2.21B |
| Shanghai Labway Clinical Laboratory | 1.52B |
| Beijing Strong Biotechnologies,Inc. | 1.43B |
| Thalys Medical Technology Group | 1.25B |
| Amoy Diagnostics | 1.13B |
| Berry Genomics Co.,Ltd | 941.16M |
| SMO ClinPlus CO.,LTD. | 819.09M |
| Cowealth Medical China | 777.03M |